These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 34616002)

  • 1. A NOS1AP gene variant is associated with a paradoxical increase of the QT-interval shortening effect of digoxin.
    Soroush N; Aarnoudse AJ; Kavousi M; Kors JA; Ikram MA; Newton-Cheh C; Ahmadizar F; Stricker BH
    Pharmacogenomics J; 2022 Feb; 22(1):55-61. PubMed ID: 34616002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NOS1AP gene rs10494366 common genetic variant does not modify the risk of sudden cardiac death in users of digoxin.
    Soroush N; Aarnoudse AJ; Kavousi M; Kors JA; Ikram MA; Stricker BH; Ahmadizar F
    Br J Clin Pharmacol; 2024 Sep; 90(9):2159-2165. PubMed ID: 38822495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam Study.
    Aarnoudse AJ; Newton-Cheh C; de Bakker PI; Straus SM; Kors JA; Hofman A; Uitterlinden AG; Witteman JC; Stricker BH
    Circulation; 2007 Jul; 116(1):10-6. PubMed ID: 17576865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of NOS1AP genetic variants with QT interval duration in families from the Diabetes Heart Study.
    Lehtinen AB; Newton-Cheh C; Ziegler JT; Langefeld CD; Freedman BI; Daniel KR; Herrington DM; Bowden DW
    Diabetes; 2008 Apr; 57(4):1108-14. PubMed ID: 18235038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium channel blockers, NOS1AP, and heart-rate-corrected QT prolongation.
    van Noord C; Aarnoudse AJ; Eijgelsheim M; Sturkenboom MC; Straus SM; Hofman A; Kors JA; Newton-Cheh C; Witteman JC; Stricker BH
    Pharmacogenet Genomics; 2009 Apr; 19(4):260-6. PubMed ID: 19247217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in the NOS1AP gene modulate QT interval duration and risk of arrhythmias in the long QT syndrome.
    Tomás M; Napolitano C; De Giuli L; Bloise R; Subirana I; Malovini A; Bellazzi R; Arking DE; Marban E; Chakravarti A; Spooner PM; Priori SG
    J Am Coll Cardiol; 2010 Jun; 55(24):2745-52. PubMed ID: 20538168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a common variant at the NOS1AP locus strongly associated to QT-interval duration.
    Eijgelsheim M; Aarnoudse AL; Rivadeneira F; Kors JA; Witteman JC; Hofman A; van Duijn CM; Uitterlinden AG; Stricker BH
    Hum Mol Genet; 2009 Jan; 18(2):347-57. PubMed ID: 18927126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender and effects of a common genetic variant in the NOS1 regulator NOS1AP on cardiac repolarization in 3761 individuals from two independent populations.
    Tobin MD; Kähönen M; Braund P; Nieminen T; Hajat C; Tomaszewski M; Viik J; Lehtinen R; Ng GA; Macfarlane PW; Burton PR; Lehtimäki T; Samani NJ
    Int J Epidemiol; 2008 Oct; 37(5):1132-41. PubMed ID: 18511491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A common variant of NOS1AP is associated with QT interval duration in a Chinese population with Type 2 diabetes.
    Lu J; Hu C; Hu W; Zhang R; Wang C; Qin W; Yu W; Xiang K; ; Jia W
    Diabet Med; 2010 Sep; 27(9):1074-9. PubMed ID: 20722683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of NOS1AP Risk Variants on the Corrected QT (QTc) Interval in the Pharmacotherapy of Schizophrenia.
    Esen-Sehir D; Kopf J; Hägele S; Plichta MM; Reif A; Freudenberg F
    Pharmacopsychiatry; 2022 Sep; 55(5):266-273. PubMed ID: 35732169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex is a moderator of the association between NOS1AP sequence variants and QTc in two long QT syndrome founder populations: a pedigree-based measured genotype association analysis.
    Winbo A; Stattin EL; Westin IM; Norberg A; Persson J; Jensen SM; Rydberg A
    BMC Med Genet; 2017 Jul; 18(1):74. PubMed ID: 28720088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common variation in NOS1AP and KCNH2 genes and QT interval duration in young adults. The Cardiovascular Risk in Young Finns Study.
    Raitakari OT; Blom-Nyholm J; Koskinen TA; Kähönen M; Viikari JS; Lehtimäki T
    Ann Med; 2009; 41(2):144-51. PubMed ID: 18785031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common candidate gene variants are associated with QT interval duration in the general population.
    Marjamaa A; Newton-Cheh C; Porthan K; Reunanen A; Lahermo P; Väänänen H; Jula A; Karanko H; Swan H; Toivonen L; Nieminen MS; Viitasalo M; Peltonen L; Oikarinen L; Palotie A; Kontula K; Salomaa V
    J Intern Med; 2009 Apr; 265(4):448-58. PubMed ID: 19019189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between genetic variants in the NOS1AP (CAPON) gene and cardiac repolarization in the old order Amish.
    Post W; Shen H; Damcott C; Arking DE; Kao WH; Sack PA; Ryan KA; Chakravarti A; Mitchell BD; Shuldiner AR
    Hum Hered; 2007; 64(4):214-9. PubMed ID: 17565224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic Meta-Analysis of the Association Between a Common NOS1AP Genetic Polymorphism, the QTc Interval, and Sudden Death.
    Zang X; Li S; Zhao Y; Chen K; Wang X; Song W; Ma J; Tu X; Xia Y; Zhang S; Gao C
    Int Heart J; 2019 Sep; 60(5):1083-1090. PubMed ID: 31447468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variations in nitric oxide synthase 1 adaptor protein are associated with sudden cardiac death in US white community-based populations.
    Kao WH; Arking DE; Post W; Rea TD; Sotoodehnia N; Prineas RJ; Bishe B; Doan BQ; Boerwinkle E; Psaty BM; Tomaselli GF; Coresh J; Siscovick DS; Marbán E; Spooner PM; Burke GL; Chakravarti A
    Circulation; 2009 Feb; 119(7):940-51. PubMed ID: 19204306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common variation in the NOS1AP gene is associated with reduced glucose-lowering effect and with increased mortality in users of sulfonylurea.
    Becker ML; Aarnoudse AJ; Newton-Cheh C; Hofman A; Witteman JC; Uitterlinden AG; Visser LE; Stricker BH
    Pharmacogenet Genomics; 2008 Jul; 18(7):591-7. PubMed ID: 18551039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of common candidate gene variants to electrocardiographic T-wave peak to T-wave end interval and T-wave morphology parameters.
    Porthan K; Marjamaa A; Viitasalo M; Väänänen H; Jula A; Toivonen L; Nieminen MS; Newton-Cheh C; Salomaa V; Kontula K; Oikarinen L
    Heart Rhythm; 2010 Jul; 7(7):898-903. PubMed ID: 20215044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis for Genetic Modifiers of Disease Severity in Patients With Long-QT Syndrome Type 2.
    Kolder ICRM; Tanck MWT; Postema PG; Barc J; Sinner MF; Zumhagen S; Husemann A; Stallmeyer B; Koopmann TT; Hofman N; Pfeufer A; Lichtner P; Meitinger T; Beckmann BM; Myerburg RJ; Bishopric NH; Roden DM; Kääb S; Wilde AAM; Schott JJ; Schulze-Bahr E; Bezzina CR
    Circ Cardiovasc Genet; 2015 Jun; 8(3):447-456. PubMed ID: 25737393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelic variant of NOS1AP effects on cardiac alternans of repolarization during exercise testing.
    Koskela J; Kähönen M; Nieminen T; Lehtinen R; Viik J; Nikus K; Niemelä K; Kööbi T; Tobin MD; Samani NJ; Turjanmaa V; Pörsti I; Lehtimäki T
    Scand J Clin Lab Invest; 2012 Apr; 72(2):100-7. PubMed ID: 22133205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.